Insider Purchases: Inside the Buy
Tag: featured-overseas
🌐 Globant (GLOB): The AI Infrastructure Tollbooth Trading at 7x Earnings
Globant (NYSE: GLOB) may be one of the most intriguing AI-related value plays on the market. Trading 87% below its peak, the company combines a growing AI-native services platform, accelerating cash flow, aggressive share buybacks, institutional ownership above 100% of float, and a historic first insider purchase from former Hong Kong Exchange CEO Alejandro Aguzin. Is Wall Street missing the story?
🐟 Nomad Foods (NOMD): The Frozen Food Giant Trading Like a Distressed Stock
Nomad Foods may not be sexy, but Europe’s frozen-food empire is suddenly attracting serious insider buying, quant fund interest, and deep-value investors. With a near-7% dividend yield, aggressive buybacks, and a forward P/E near 5x, NOMD might be one of the market’s coldest contrarian opportunities.
💼 Willis Towers Watson (WTW): The Quiet Compounder Smart Money Keeps Buying
WTW isn’t flashy—but when the CEO buys the dip and institutions own nearly everything, it’s worth a closer look. A quiet compounder trading at a rare discount.
🏟️ Sportradar (SRAD): The Picks & Shovels Powering the Global Betting Boom
Sportradar (SRAD) isn’t betting on games—it’s monetizing the entire betting ecosystem. With insiders loading up, free cash flow surging, and valuation resetting, this “picks & shovels” play may be one of the smartest ways to ride the global sports betting boom.
AbCellera (ABCL) Stock Analysis: 7 Triggers for a Biotech Short Squeeze or Long-Term Multibagger?
Down 95%, heavily shorted, yet sitting on $700M in liquidity and insider conviction — AbCellera (ABCL) may be biotech’s ultimate asymmetric bet.